Essentially, knockdown of TS greatly elevated membrane-bound PD-L1 levels in CL1-5 and CL141 cells (figure 5B), thereby enhancing the ability of tumor cells to suppress Jurkat T-cell or CTL activation (figure 5G). The gene discussed is TYMS; the disease is neoplasm.